1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: May 24-30, 2026
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: May 24-30, 2026

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Kyle Diamantas, J.D., Acting Commissioner of Food and Drugs
No Significant Event

Official Name: Sean R. Keveney, J.D., Chief Counsel
Event Date: 05/27/2026
Location: Washington, DC
Subject: Drug Shortage
FDA Participant/Group: N/A
Non FDA Participant/Group: Bill Holtz, John Strom (Foley Hoag);

Official Name: Grace Graham, Deputy Commissioner for Policy, Legislation, and International Affairs
Event Date: 05/27/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Beena Patel, Michael Brzica, Nimi Chhina (Teva Pharmaceuticals);

Event Date: 05/28/2026
Location: Virtual
Subject: Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Seth Lieblich (8VC);

Official Name: Lowell Zeta, J.D., Deputy Commissioner for Strategic Initiatives
Event Date: 05/26/2026
Location: Silver Spring, MD
Subject: Vapor Technologies Austin Meeting
FDA Participant/Group: BRIAN FAHEY; BRET KOPLOW; LUKE HALL;
Non FDA Participant/Group: Brad Humphreys, Derek Lyons, Michael Rubin, Tony Lyons (Vapor Technologies Austin);

Event Date: 05/27/2026
Location: Virtual
Subject: Replimune Meeting
FDA Participant/Group: SEAN KEVENEY;
Non FDA Participant/Group: Lynn Mehler (Paul Hastings LLP); Joshua T. Hoyt (Executive Office of the President (EOP)); Kari Jeschke, Sush Patel (Replimune);

Event Date: 05/29/2026
Location: Virtual
Subject: Tavneos Meeting
FDA Participant/Group: SEAN KEVENEY;
Non FDA Participant/Group: Jay Bradner, Jon Graham (Amgen); Rebecca Wood (Sidley Austin LLP);

Official Name: Donald A. Prater, D.V.M., Acting Deputy Commissioner for Food
No Significant Event

Official Name: Melanie Keller, M.B.A., Deputy Commissioner for Operations and Chief Operating Officer
No Significant Event

Official Name: Elizabeth Miller, Pharm.D., Associate Commissioner for Inspections and Investigations
No Significant Event

Official Name: Karim Mikhail, B.Pharm, MSc, Acting Director, Center for Biologics Evaluation and Research
No Significant Event

Official Name: Michelle Tarver, M.D., Ph.D., Director, Center for Devices and Radiological Health
Event Date: 05/26/2026
Location: Silver Spring, MD
Subject: General Medical Device Updates
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Boston Scientific representatives

Official Name: Michael Davis, M.D., Ph.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event

Official Name: Bret Koplow, Ph.D., J.D., Acting Director, Center for Tobacco Products
No Significant Event

Official Name: Timothy C. Schell, Ph.D., Director, Center for Veterinary Medicine
Event Date: 05/28/2026
Location: College Park, MD
Subject: Veterinary Issues of Mutual Interest
FDA Participant/Group: DOROTHY BAILEY; MATTHEW LUCIA; WILLIAM FLYNN; CINDY BURNSTEEL;
Non FDA Participant/Group: Boehringer Ingelheim representatives

Back to Top